Catalog
See full images - free registration
Continue with Google - no registration!
or register with email
Why register? Just to keep bots out of our catalog. Your email stays private - we will never share it or send you anything uninvited. We guarantee you that!
2 Cedis Ugur Sahin and Özlem Türeci
| Issuer | Ghana |
|---|---|
| Year | 2022 |
| Type | Log in to see details |
| Value | 2 Cedis |
| Currency | Log in to see details |
| Composition | Log in to see details |
| Weight | Log in to see details |
| Diameter | Log in to see details |
| Thickness | Log in to see details |
| Shape | Log in to see details |
| Technique | Log in to see details |
| Orientation | Log in to see details |
| Engraver(s) | Log in to see details |
| In circulation to | Log in to see details |
| Reference(s) | Log in to see details |
| Obverse description | Effigy of Queen Elizabeth II facing right, as designed by Ian Rank-Broadley, wearing the Girls of Great Britain and Ireland tiara; the engraver's initials IRB appear below the portrait truncation. The circular legend along the upper rim reads ELIZABETH II · REPUBLIC OF GHANA, with 2 CEDIS to the right. The lower rim bears the date 2022, the Ghanaian coat of arms, and the metallic specification TI .990 1 OZ, all within a raised border. |
|---|---|
| Obverse script | Latin |
| Obverse lettering | Log in to see details |
| Reverse description | Conjoined busts of BioNTech co-founders Uğur Şahin (left) and Özlem Türeci (right) facing slightly toward one another, set against a stylised dotted globe motif in the field, evoking a viral or molecular pattern. Between the two portraits, in the lower central field, appears the inscription COVID-19 VACCINE in relief. The surrounding legend reads TITANS OF GERMAN INNOVATION along the upper arc, and UĞUR ŞAHİN & ÖZLEM TÜRECI along the lower arc, all within a raised rim. |
| Reverse script | Log in to see details |
| Reverse lettering | Log in to see details |
| Edge | Log in to see details |
| Mint | Log in to see details |
| Mintage | Log in to see details |
| Additional information | Log in to see details |